21.2 C
New York
Thursday, June 18, 2026

Tag: recognition

newssourceFORcompanyinformationcontent1marketreleases

TraceLink Wins ISM Supply Chain Trailblazer Award for OPUS, Advancing Real-Time Multienterprise Supply Chain Execution

Recognition highlights the impact of OPUS, the Orchestration Platform for Universal Solutions, in helping life sciences and healthcare companies digitalize multienterprise transactions and processes...

10-Person Legacy MEDSearch Named to Forbes America’s Best Executive / Professional Recruiting Firms for the Tenth Time

The Only Exclusively MedTech Firm Among the Top 175 of 22,000+ US Recruiting Firms.ORLANDO, Fla., June 9, 2026 /PRNewswire/ -- For the tenth time...

Liquisite and eMazzanti Technologies Deliver Enterprise-Grade Digital Marketing, With the Brand Growth Backbone Your Business Demands

A flexible, ROI-driven platform combining award-winning web design, deep digital marketing expertise, and decades of cybersecurity leadershipHOBOKEN, N.J., June 9, 2026 /PRNewswire/ -- In...

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Sportradar Group AG Investors to Secure Counsel Before Important Deadline in Securities Class Action – SRAD

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A ordinary shares of Sportradar Group AG (NASDAQ: SRAD) between November 7, 2024 and April 21, 2026, inclusive (the “Class Period”), of the important July 17, 2026 lead plaintiff deadline.

Legal Win for Tsetsaut Skii km Lax Ha Nation: B.C. Supreme Court Strikes Down Substantial Start Determination for KSM Mine and Orders Proper Consultation;...

HAZELTON, BC, June 9, 2026 /CNW/ - Yesterday, the B.C. Supreme Court issued its decision on the Tsetsaut Skii km Lax Ha (TSKLH) Nation's...

Actuate Therapeutics’ Elraglusib Selected for Evaluation in BEACON2 Trial for High-Risk Pediatric Neuroblastoma

- BEACON2 is a landmark European multi-arm, multi-stage Phase 1/2 platform trial conducted and sponsored by the Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham 

- Elraglusib will be assessed in combination with dinutuximab beta plus chemotherapy in patients with relapsed and refractory neuroblastoma

- Complete response in neuroblastoma patient achieved in Phase 1 study of elraglusib in refractory pediatric cancers

UNHCR Recognizes Climate-Resilient Drinking Water Planning Tool as Global Compact on Refugees Good Practice

UNHCR recognizes EPHI’s LSLRCC as a Global Compact on Refugees Good Practice supporting climate-resilient drinking water planning.

Lithia & Driveway (LAD) Rises to Number 123 on 2026 Fortune 500 List

Lithia & Driveway (LAD) Rises to Number 123 on 2026 Fortune 500 List

Documentary “The Pl*nt” Arrives on Amazon Prime Video with a Landmark Final Interview from Dr. Raphael Mechoulam

Now streaming on Amazon Prime Video in Spain, 'The Pl*nt' combines Ferran Calbet's cinematic direction for HighVideo Films, in collaboration with Royal Queen Seeds. At its centre is what is believed to be Dr. Raphael Mechoulam's final filmed interview, offering a powerful exploration of cannabis science, history and stigma.

Beauty of Joseon Named ‘Global No.1 K-Beauty Suncare Brand in Online Sales’ by Euromonitor International

SEOUL, South Korea, June 9, 2026 /PRNewswire/ -- Beauty of Joseon has been recognized by global market intelligence company Euromonitor International as the "Global No.1...

Antaisolar Showcases Upgraded 2P Tracker Solution at SNEC 2026, Securing Multiple Global Partnerships

XIAMEN, China, June 9, 2026 /PRNewswire/ -- Fresh from being ranked No.7 in Wood Mackenzie's 2026 global PV tracker TOP10 and named a Global A-Class...

Beauty of Joseon Named ‘Global No.1 K-Beauty Suncare Brand in Online Sales’ by Euromonitor International

SEOUL, South Korea, June 9, 2026 /PRNewswire/ -- Beauty of Joseon has been recognized by global market intelligence company Euromonitor International as the "Global No.1...

Zepp Health Corporation Reports First Quarter of 2026 Unaudited Financial Results

MILPITAS, Calif., June 8, 2026 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today announced its unaudited financial results for the...

DNOW Investor News: If You Have Suffered Losses in DNOW Inc. (NYSE: DNOW), You Are Encouraged to Contact The Rosen Law Firm About Your...

NEW YORK, June 08, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of DNOW Inc. (NYSE: DNOW) resulting from allegations that DNOW Inc. may have issued materially misleading business information to the investing public.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRecognition

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers